{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:56:44Z","timestamp":1779029804029,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23MH085005"],"award-info":[{"award-number":["K23MH085005"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21MH080968"],"award-info":[{"award-number":["R21MH080968"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RR024979"],"award-info":[{"award-number":["RR024979"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jpeds.2018.05.040","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T05:08:24Z","timestamp":1530076104000},"page":"245-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys"],"prefix":"10.1016","volume":"201","author":[{"given":"Chadi A.","family":"Calarge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lefkothea","family":"Karaviti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6164-7348","authenticated-orcid":false,"given":"Babette S.","family":"Zemel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2018.05.040_bib0010","series-title":"Antidepressant use among persons aged 12 and over: United States, 2011-2014","author":"Pratt","year":"2017"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.euroneuro.2016.02.001","article-title":"Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012","volume":"26","author":"Bachmann","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0020","series-title":"Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008","author":"Gu","year":"2010"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0025","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3943","article-title":"Body composition in adolescents during treatment with selective serotonin reuptake inhibitors","volume":"140","author":"Calarge","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1089\/cap.2004.14.412","article-title":"Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents","volume":"14","author":"Nilsson","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0035","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/01.chi.0000172535.24534.44","article-title":"Fluoxetine for depression relapse prevention","volume":"44","author":"Calarge","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0040","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.chi.0000140453.89323.57","article-title":"Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study","volume":"43","author":"Emslie","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0045","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archpedi.156.7.696","article-title":"Decreased growth during therapy with selective serotonin reuptake inhibitors","volume":"156","author":"Weintrob","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0050","series-title":"Prozac (fluoxetine hydrochloride) package insert","author":"Company ELa","year":"2005"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2015.05.042","article-title":"Bone growth in juvenile rhesus monkeys is influenced by 5HTTLPR polymorphisms and interactions between 5HTTLPR polymorphisms and fluoxetine","volume":"79","author":"Golub","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0060","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1210\/jc.2013-4455","article-title":"Age-based reference ranges for annual height velocity in US children","volume":"99","author":"Kelly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0065","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1176\/appi.ajp.161.5.918","article-title":"Growth and sexual maturation during long-term treatment with risperidone","volume":"161","author":"Dunbar","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/cap.2010.0018","article-title":"Some effects of risperidone and quetiapine on growth parameters and hormone levels in young pigtail macaques","volume":"20","author":"Sackett","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4088\/JCP.14m09195","article-title":"Longitudinal examination of the skeletal effects of selective serotonin reuptake inhibitors and risperidone in boys","volume":"76","author":"Calarge","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/cap.2017.0104","article-title":"Calcium and Vitamin D supplementation in boys with risperidone-induced hyperprolactinemia: a randomized, placebo-controlled pilot study","volume":"28","author":"Calarge","year":"2018","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0085","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s10803-017-3097-1","article-title":"Bone mass in boys with autism spectrum disorder","volume":"47","author":"Calarge","year":"2017","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0090","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jpeds.2015.03.005","article-title":"The effect of psychostimulants on skeletal health in boys co-treated with risperidone","volume":"166","author":"Calarge","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0095","doi-asserted-by":"crossref","first-page":"e652","DOI":"10.1038\/tp.2015.135","article-title":"Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children","volume":"5","author":"Bahr","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/cap.2013.0126","article-title":"Cardiometabolic outcomes in children and adolescents following discontinuation of long-term risperidone treatment","volume":"24","author":"Calarge","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0105","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jpeds.2012.05.051","article-title":"Rate of weight gain and cardiometabolic abnormalities in children and adolescents","volume":"161","author":"Calarge","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/cap.2008.007","article-title":"Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents","volume":"19","author":"Calarge","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0115","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4088\/JCP.10m06198","article-title":"Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics","volume":"72","author":"Calarge","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0120","series-title":"Diagnostic and statistical manual of mental disorders, text revision","author":"Association AP","year":"2000"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00004583-200001000-00014","article-title":"NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses","volume":"39","author":"Shaffer","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0130","series-title":"Manual for the ASEBA school-age froms & profiles","author":"Achenbach","year":"2001"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/peds.109.1.45","article-title":"Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version","volume":"109","author":"Ogden","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0140","series-title":"Linear mixed models for longitudinal data","author":"Verbeke","year":"2000"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0145","series-title":"Statistical analysis with missing data","author":"Little","year":"2002"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0150","series-title":"Applied longitudinal analysis","author":"Fitzmaurice","year":"2011"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0155","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/adc.2004.056952","article-title":"Growth on stimulant medication; clarifying the confusion: a review","volume":"90","author":"Poulton","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0160","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1542\/peds.102.S3.501","article-title":"Growth deficits in children with attention deficit hyperactivity disorder","volume":"102","author":"Spencer","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0165","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/cap.2012.0095","article-title":"The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression","volume":"23","author":"Mansoor","year":"2013","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0170","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.299.8.901","article-title":"Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial","volume":"299","author":"Brent","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.13172\/2052-7829-1-2-520","article-title":"Serotonin\/growth hormone\/insulin-like growth factors axis on pre- and post-natal development: a contemporary review","volume":"1","author":"Musumeci","year":"2013","journal-title":"OA Anatomy"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0180","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4274\/jcrpe.2007","article-title":"Relationship between timing of peak height velocity and pubertal staging in boys and girls","volume":"7","author":"Granados","year":"2015","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0185","first-page":"1195","article-title":"Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty","volume":"78","author":"Albertsson-Wikland","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0190","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1210\/jcem-73-2-428","article-title":"Spontaneous growth hormone secretion increases during puberty in normal girls and boys","volume":"73","author":"Rose","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1203\/PDR.0b013e318193594a","article-title":"Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes","volume":"65","author":"Davidson","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0306-4530(97)00046-2","article-title":"Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients","volume":"22","author":"Deuschle","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0205","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.psyneuen.2013.07.009","article-title":"Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment","volume":"38","author":"Li","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0210","first-page":"126","article-title":"Measuring growth hormone and insulin-like growth factor-I in infants: what is normal?","volume":"11","author":"Hawkes","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0215","doi-asserted-by":"crossref","first-page":"e935","DOI":"10.1542\/peds.2014-0428","article-title":"ADHD, stimulant treatment, and growth: a longitudinal study","volume":"134","author":"Harstad","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0220","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1542\/peds.51.4.660","article-title":"Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children","volume":"51","author":"Safer","year":"1973","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0225","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/jcpp.12684","article-title":"Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit\/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression","volume":"58","author":"Swanson","year":"2017","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0230","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee","volume":"83","author":"Carroll","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ehb.2009.06.004","article-title":"Height, wealth, and health: an overview with new data from three longitudinal studies","volume":"7","author":"Batty","year":"2009","journal-title":"Econ Hum Biol"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0240","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/adc.77.4.326","article-title":"Family conflict and slow growth","volume":"77","author":"Montgomery","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0245","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0277-9536(94)00379-8","article-title":"Short stature as an effect of economic and social conditions in childhood","volume":"41","author":"Peck","year":"1995","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0250","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/aje\/kwg173","article-title":"Adult height and cause-specific mortality: a large prospective study of South Korean men","volume":"158","author":"Song","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0255","doi-asserted-by":"crossref","first-page":"e2411","DOI":"10.1097\/MD.0000000000002411","article-title":"Significantly higher peripheral insulin-like growth factor-1 levels in patients with major depressive disorder or bipolar disorder than in healthy controls: a meta-analysis and review under guideline of PRISMA","volume":"95","author":"Tu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0260","series-title":"Diagnostic and statistical manual of mental disorders, fifth edition","author":"Association AP","year":"2013"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0265","doi-asserted-by":"crossref","first-page":"69S","DOI":"10.1097\/00004583-199710001-00006","article-title":"Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. American Academy of Child and Adolescent Psychiatry","volume":"36","author":"Bernstein","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0270","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/chi.0b013e318145ae1c","article-title":"Practice parameter for the assessment and treatment of children and adolescents with depressive disorders","volume":"46","author":"Birmaher","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0275","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jpeds.2010.04.025","article-title":"A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects","volume":"157","author":"Biederman","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0280","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ehb.2009.04.002","article-title":"A head above the rest: height and adolescent psychological well-being","volume":"7","author":"Rees","year":"2009","journal-title":"Econ Hum Biol"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0285","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/jbmr.3238","article-title":"The effect of depression, generalized anxiety, and selective serotonin reuptake inhibitors on change in bone metabolism in adolescents and emerging adults","volume":"32","author":"Calarge","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jpeds.2018.05.040_bib0290","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1017\/S2040174411000808","article-title":"Prenatal exposure to selective serotonin reuptake inhibitors and risk of childhood overweight","volume":"3","author":"Grzeskowiak","year":"2012","journal-title":"J Dev Orig Health Dis"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347618307534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347618307534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:28:42Z","timestamp":1762208922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347618307534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":57,"alternative-id":["S0022347618307534"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.05.040","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.07.107","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}